Molecular and cellular mechanisms of liver fibrosis and its regression
The DOI matches its Crossref record; 296 of the 299 references it cites were found in a registry or an index.
Abstract
Chronic liver injury leads to liver inflammation and fibrosis, through which activated myofibroblasts in the liver secrete extracellular matrix proteins that generate the fibrous scar. The primary source of these myofibroblasts are the resident hepatic stellate cells. Clinical and experimental liver fibrosis regresses when the causative agent is removed, which is associated with the elimination of these activated myofibroblasts and resorption of the fibrous scar. Understanding the mechanisms of liver fibrosis regression could identify new therapeutic targets to treat liver fibrosis. This Review summarizes studies of the molecular mechanisms underlying the reversibility of liver fibrosis, including apoptosis and the inactivation of hepatic stellate cells, the crosstalk between the liver and the systems that orchestrate the recruitment of bone marrow-derived macrophages (and other inflammatory cells) driving fibrosis resolution, and the interactions between various cell types that lead to the intracellular signalling that induces fibrosis or its regression. We also discuss strategies to target hepatic myofibroblasts (for example, via apoptosis or inactivation) and the myeloid cells that degrade the matrix (for example, via their recruitment to fibrotic liver) to facilitate fibrosis resolution and liver regeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fibrosis is a characteristic feature of chronic liver disease regardless of the etiology (1).”
From Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis (2024) · cites this paper as [1]
In the citing paper
“Most of the existing knowledge regarding liver fibrosis resolution is derived from mouse models of chemical (CCl4 or acetaminophen)-induced fibrosis and regression (17–21).”
From Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2 (2024) · cites this paper as [21]
In the citing paper
“Despite clear evidence that liver fibrosis is reversible, direct anti-fibrotic therapies are still lacking [7].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [7]
In the citing paper
“Besides HSCs, other cells, including portal fibroblasts (particularly in cholestatic liver fibrosis), bone marrow-derived fibrocytes, and MSCs contribute to the pool of MFs as well, albeit to a minor extent [7, 13].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [7]
In the citing paper
“Despite clear evidence that liver fibrosis is reversible, direct anti-fibrotic therapies are still lacking [7].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [7]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Items 201–296 of 296
Bollyky, P. L., Falk, B. A., Wu, R. P., Buckner, J. H., Wight, T. N., & Nepom, G. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109001 · Cited by 153
Mazzocca, A., Dituri, F., Lupo, L., Quaranta, M., Antonaci, S., & Giannelli, G. (2011) · Hepatology · doi:10.1002/hep.24485 · Cited by 153
Histopathological evaluation of liver fibrosis and cirrhosis regression
Lo, R. C., & Kim, H. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0078 · Cited by 151
Desmoulière, A., Darby, I. A., Costa, A., Raccurt, M., Tuchweber, B., Sommer, P., & Gabbiani, G. (1997) · PubMed · Cited by 146
Involvement of Hyaluronan in Regulation of Fibroblast Phenotype
Meran, S., Thomas, D., Stephens, P., Martin, J., Bowen, T., Phillips, A., & Steadman, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700773200 · Cited by 146
Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics
Feldman, A. G., & Sokol, R. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0132-z · Cited by 144
Hafeez, S., & Ahmed, M. H. (2013) · Journal of Obesity · doi:10.1155/2013/839275 · Cited by 144
Epithelial-Mesenchymal Transition
Zavadil, J., Haley, J., Kalluri, R., Muthuswamy, S. K., & Thompson, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2316 · Cited by 143
Gomperts, B. N., & Strieter, R. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906587 · Cited by 142
Popov, Y., Sverdlov, D. Y., Sharma, A. K., Bhaskar, K. R., Li, S., Freitag, T. L., Lee, J., Dieterich, W., Melino, G., & Schuppan, D. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.040 · Cited by 137
Xiang, M., Wang, P., Wang, A., Zhang, X., Zhang, Y., Zhang, P., Mei, F., Chen, M., & Li, H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.002 · Cited by 137
Puche, J. E., Lee, Y. A., Jiao, J., Aloman, C., Fiel, M. I., Muñoz, U., Kraus, T., Lee, T., Yee, H. F., & Friedman, S. L. (2013) · Hepatology · doi:10.1002/hep.26053 · Cited by 136
Popov, Y., Sverdlov, D. Y., Bhaskar, K. R., Sharma, A. K., Millonig, G., Patsenker, E., Krahenbuhl, S., Krahenbuhl, L., & Schuppan, D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00394.2009 · Cited by 136
Webber, J., Meran, S., Steadman, R., & Phillips, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806989200 · Cited by 136
Nishio, T., Hu, R., Koyama, Y., Liang, S., Rosenthal, S. B., Yamamoto, G., Karin, D., Baglieri, J., Ma, H.-Y., Xu, J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.012 · Cited by 135
Self-citationPerugorria, M. J., Wilson, C. L., Zeybel, M., Walsh, M., Amin, S., Robinson, S., White, S. A., Burt, A. D., Oakley, F., Tsukamoto, H., et al. (2012) · Hepatology · doi:10.1002/hep.25754 · Cited by 134
Moreno, M., Gonzalo, T., Kok, R. J., Sancho-Bru, P., van Beuge, M., Swart, J., Prakash, J., Temming, K., Fondevila, C., Beljaars, L., et al. (2010) · Hepatology · doi:10.1002/hep.23419 · Cited by 132
Self-citationZhang, L. P., Takahara, T., Yata, Y., Furui, K., Jin, B., Kawada, N., & Watanabe, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80351-1 · Cited by 127
Ratziu, V., Sanyal, A. J., Loomba, R., Rinella, M., Harrison, S., Anstee, Q. M., Goodman, Z., Bedossa, P., MacConell, L., Shringarpure, R., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.06.017 · Cited by 126
Hepatocellular carcinoma: Where are we?
Mazzanti, R. (2016) · World Journal of Experimental Medicine · doi:10.5493/wjem.v6.i1.21 · Cited by 126
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice
Xie, G., Karaca, G., Swiderska-Syn, M., Michelotti, G. A., Krüger, L., Chen, Y., Premont, R. T., Choi, S. S., & Diehl, A. M. (2013) · Hepatology · doi:10.1002/hep.26511 · Cited by 125
Kluwe, J., Wongsiriroj, N., Troeger, J. S., Gwak, G.-Y., Dapito, D. H., Pradere, J.-P., Jiang, H., Siddiqi, M., Piantedosi, R., O'Byrne, S. M., et al. (2011) · Gut · doi:10.1136/gut.2010.209551 · Cited by 121
Kendall, T. J., Hennedige, S., Aucott, R. L., Hartland, S. N., Vernon, M. A., Benyon, R. C., & Iredale, J. P. (2009) · Hepatology · doi:10.1002/hep.22701 · Cited by 121
Peng, Z., Ikenaga, N., Liu, S. B., Sverdlov, D. Y., Vaid, K. A., Dixit, R., Weinreb, P. H., Violette, S., Sheppard, D., Schuppan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28274 · Cited by 118
Migration of Fibrocytes in Fibrogenic Liver Injury
Scholten, D., Reichart, D. R., Paik, Y. H., Lindert, J., Bhattacharya, J., Glass, C. K., Brenner, D. A., & Kisseleva, T. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.049 · Cited by 116
Self-citationMaltby, J. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008903391 · Cited by 116
The potential for caspases in drug discovery.
MacKenzie, S. H., Schipper, J. L., & Clark, A. C. (2010) · PubMed · Cited by 114
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
Yang, L., Bataller, R. A., Dulyx, J., Coffman, T. M., Ginès, P., Rippe, R. A., & Brenner, D. A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.034 · Cited by 114
Self-citationKim, C.-W., Addy, C., Kusunoki, J., Anderson, N. N., Deja, S., Fu, X., Burgess, S. C., Cai, L., Ruddy, M., Chakravarthy, M. V., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.011 · Cited by 112
Shiffman, M., Freilich, B., Vuppalanchi, R., Watt, K., Chan, J. L., Spada, A., Hagerty, D. T., & Schiff, E. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15030 · Cited by 112
Liu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P. R., Dooley, S., & Weng, H.-L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003260 · Cited by 111
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Koyama, Y., Wang, P., Liang, S., Iwaisako, K., Liu, X., Xu, J., Zhang, M., Sun, M., Cong, M., Karin, D., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88845 · Cited by 111
Self-citationKong, X., Feng, D., Mathews, S., & Gao, B. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12032 · Cited by 108
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases
Sonoda, J., Chen, M. Z., & Baruch, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0002 · Cited by 105
Liu, C., Chen, X., Yang, L., Kisseleva, T., Brenner, D. A., & Seki, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.543769 · Cited by 103
Self-citationNuclear Receptor Regulation of the Adaptive Response of Bile Acid Transporters in Cholestasis
Wagner, M., Zollner, G., & Trauner, M. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1253225 · Cited by 102
Reversibility of liver fibrosis
Ramachandran, P., & Iredale, J. P. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31740-5 · Cited by 98
Paquissi, F. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01195 · Cited by 93
Maricic, I., Marrero, I., Eguchi, A., Nakamura, R., Johnson, C. D., Dasgupta, S., Hernandez, C. D., Nguyen, P. S., Swafford, A. D., Knight, R., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800614 · Cited by 92
Tornesello, M. L., Buonaguro, L., Izzo, F., & Buonaguro, F. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7837 · Cited by 92
Prospective Isolation of Mesenchymal Stem Cells from Mouse Compact Bone
Short, B. J., Brouard, N., & Simmons, P. J. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-060-7_16 · Cited by 85
Neutrophils alleviate fibrosis in the CCl4-induced mouse chronic liver injury model
Saijou, E., Enomoto, Y., Matsuda, M., Yuet‐Yin Kok, C., Akira, S., Tanaka, M., & Miyajima, A. (2018) · Hepatology Communications · doi:10.1002/hep4.1178 · Cited by 84
Lysophosphatidic acid-1-receptor targeting agents for fibrosis
Rancoule, C., Pradère, J.-P., Gonzalez, J., Klein, J., Valet, P., Bascands, J.-L., Schanstra, J. P., & Saulnier-Blache, J.-S. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.566864 · Cited by 84
Ling, H., Roux, E., Hempel, D., Tao, J., Smith, M., Lonning, S., Zuk, A., Arbeeny, C., & Ledbetter, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054499 · Cited by 82
SUDO, K., YAMADA, Y., MORIWAKI, H., SAITO, K., & SEISHIMA, M. (2005) · Cytokine · doi:10.1016/j.cyto.2004.11.001 · Cited by 80
Duffy, A. G., Ma, C., Ulahannan, S. V., Rahma, O. E., Makarova-Rusher, O., Cao, L., Yu, Y., Kleiner, D. E., Trepel, J., Lee, M.-J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3171 · Cited by 80
Caspase Inhibitors: A Pharmaceutical Industry Perspective
LINTON, S. J. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802605775009720 · Cited by 79
Qu, K., Huang, Z., Lin, T., Liu, S., Chang, H., Yan, Z., Zhang, H., & Liu, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00300 · Cited by 75
Methylsulfonylmethane inhibits NLRP3 inflammasome activation
Ahn, H., Kim, J., Lee, M.-J., Kim, Y. J., Cho, Y., & Lee, G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.11.001 · Cited by 71
Rowbottom, M. W., Bain, G., Calderon, I., Lasof, T., Lonergan, D. G., Lai, A. G., Huang, F., Darlington, J. V., Prodanovich, P., Santini, A. M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00345 · Cited by 71
Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy
Lynch, S. M., & Wu, G. Y. (2016) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00027 · Cited by 69
The Role of Matrix Stiffness in Hepatic Stellate Cell Activation and Liver Fibrosis
Gaca, M., Georges, P., Hui, J., Janmey, P., & Wells, R. (2005) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2005.130117aa.x · Cited by 68
Bosselut, N., Housset, C., Marcelo, P., Rey, C., Burmester, T., Vinh, J., Vaubourdolle, M., Cadoret, A., & Baudin, B. (2010) · PROTEOMICS · doi:10.1002/pmic.200900257 · Cited by 66
Isolation of Non-parenchymal Cells from the Mouse Liver
Mohar, I., Brempelis, K. J., Murray, S. A., Ebrahimkhani, M. R., & Crispe, I. N. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2815-6_1 · Cited by 66
Massey, V. L., Dolin, C. E., Poole, L. G., Hudson, S. V., Siow, D. L., Brock, G. N., Merchant, M. L., Wilkey, D. W., & Arteel, G. E. (2017) · Hepatology · doi:10.1002/hep.28918 · Cited by 64
CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice
Ishikawa, S., Ikejima, K., Yamagata, H., Aoyama, T., Kon, K., Arai, K., Takeda, K., & Watanabe, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.022 · Cited by 64
Lu, M., Li, J., Zhang, T., Rupp, L. B., Trudeau, S., Holmberg, S. D., Moorman, A. C., Spradling, P. R., Teshale, E. H., Xu, F., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.01.009 · Cited by 63
Abu Dayyeh, B. K., Yang, M., Dienstag, J. L., & Chung, R. T. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1507-8 · Cited by 62
Huby, A.-C., Rastaldi, M.-P., Caron, K. M., Smithies, O., Dussaule, J., & Chatziantoniou, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006721 · Cited by 62
Blockade of renin–angiotensin system in antifibrotic therapy
Yoshiji, H., Kuriyama, S., & Fukui, H. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04663.x · Cited by 60
Lua, I., James, D., Wang, J., Wang, K. S., & Asahina, K. (2014) · Hepatology · doi:10.1002/hep.27035 · Cited by 59
Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model
Karhadkar, T. R., Pilling, D., Cox, N., & Gomer, R. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-15198-8 · Cited by 58
Giannone, F. A., Baldassarre, M., Domenicali, M., Zaccherini, G., Trevisani, F., Bernardi, M., & Caraceni, P. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.191 · Cited by 57
Wang, Y., Ghoshal, S., Ward, M. R., de Villiers, W. J. S., Woodward, J. G., & Eckhardt, E. R. M. (2010) · PLoS ONE · doi:10.1371/annotation/bc95caf3-62cf-4ecd-8a79-9116e62f4a50 · Cited by 57
Wang, Y., Abarbanell, A. M., Herrmann, J. L., Weil, B. R., Manukyan, M. C., Poynter, J. A., & Meldrum, D. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014206 · Cited by 54
Hepatic stellate cells and intralobular innervation in human liver cirrhosis
Ueno, T., Sata, M., Sakata, R., Torimura, T., Sakamoto, M., Sugawara, H., & Tanikawa, K. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90011-3 · Cited by 53
Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1
Fan, X., Zhang, Q., Li, S., Lv, Y., Su, H., Jiang, H., & Hao, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082190 · Cited by 53
The Attraction of Color for Active Attention-Problem Children
Zentall, S. S., & Kruczek, T. (1988) · Exceptional Children · doi:10.1177/001440298805400411 · Cited by 52
Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury
Dudas, J., Mansuroglu, T., Batusic, D., & Ramadori, G. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0503-y · Cited by 50
Genetic variants in candidate genes influencing NAFLD progression
Rosa, M. D., & Malaguarnera, L. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0803-x · Cited by 50
Maretti‐Mira, A. C., Wang, X., Wang, L., & DeLeve, L. D. (2019) · Hepatology · doi:10.1002/hep.30227 · Cited by 49
Inactivation of myofibroblasts during regression of liver fibrosis
Kisseleva, T., & Brenner, D. A. (2013) · Cell Cycle · doi:10.4161/cc.23549 · Cited by 47
Self-citationMeurer, S. K., Alsamman, M., Sahin, H., Wasmuth, H. E., Kisseleva, T., Brenner, D. A., Trautwein, C., Weiskirchen, R., & Scholten, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056116 · Cited by 47
Self-citationPrise, K. M., Folkard, M., Davies, S., & Michael, B. D. (1989) · Radiation Research · doi:10.2307/3577354 · Cited by 43
Wahsh, E., Abu‐Elsaad, N., El-Karef, A., & Ibrahim, T. M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.07.052 · Cited by 43
Yoshiji, H., Noguchi, R., Ikenaka, Y., Kitade, M., Kaji, K., Tsujimoto, T., Uemura, M., & Fukui, H. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782360169 · Cited by 42
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Yanase, K., Namisaki, T., Yamazaki, M., Tsujinoue, H., Imazu, H., et al. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00160-8 · Cited by 41
Kisseleva, T., von Köckritz-Blickwede, M., Reichart, D., McGillvray, S. M., Wingender, G., Kronenberg, M., Glass, C. K., Nizet, V., & Brenner, D. A. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0756-0 · Cited by 40
Self-citationInflammation and TGFβ1: Lessons from the TGFβ1 null mouse
Kulkarni, A. B., & Karlsson, S. (1997) · Research in Immunology · doi:10.1016/s0923-2494(97)82669-7 · Cited by 38
Contribution of bone marrow-derived fibrocytes to liver fibrosis.
Xu, J., Cong, M., Park, T. J., Scholten, D., Brenner, D. A., & Kisseleva, T. (2015) · PubMed · doi:10.3978/j.issn.2304-3881.2015.01.01 · Cited by 37
Self-citationInhibition of Human Neutrophil Extracellular Trap (NET) Production by Propofol and Lipid Emulsion
Meier, A., Chien, J., Hobohm, L., Patras, K. A., Nizet, V., & Corriden, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00323 · Cited by 37
Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer
Hah, N., Sherman, M. H., Yu, R. T., Downes, M., & Evans, R. M. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027185 · Cited by 31
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Kallis, Y. N., & Forbes, S. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.026 · Cited by 28
Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease?
Ding, N., Liddle, C., Evans, R. M., & Downes, M. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.841078 · Cited by 28
Cholestasis and cholestatic syndromes
Hirschfield, G. M., & Heathcote, E. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32832914b4 · Cited by 27
Mei, S. L. G. C. Y., Thompson, A. J. V., Christensen, B., Cunningham, G., McDonald, L., Bell, S., Iser, D. M., Nguyen, T., & Desmond, P. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185609 · Cited by 26
Goddard, C., Smith, A., Hoyland, J. A., Baird, P., McMahon, R. F., Freemont, A. J., Shomaf, M. S., Haboubi, N. Y., & Warnes, T. W. (1998) · Gut · doi:10.1136/gut.43.3.433 · Cited by 25
Verna, E. C., Patel, J. R., Bettencourt, R., Nguyen, P. T., Hernandez, C., Valasek, M. A., Kisselva, T., Brenner, D. A., & Loomba, R. S. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13292 · Cited by 24
Self-citationHarting, M. T., Jiménez, F., & Cox, C. S. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0046 · Cited by 22
IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice
Wei, J., Shi, M., Wu, W.-Q., Xu, H., Wang, T., Wang, N., Ma, J.-L., & Wang, Y.-G. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i47.5203 · Cited by 19
Inhibition of plasminogen activator inhibitor‐1 expression by siRNA in rat hepatic stellate cells
Hu, P., Zhu, Y., Zhong, W. H., Chen, Y.-X., Lin, Y., Zhang, X., Yin, C., Yue, H., & Xie, W. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05485.x · Cited by 19
Gehrke, N., Nagel, M., Straub, B. K., Wörns, M., Schuchmann, M., Galle, P. R., & Schattenberg, J. M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00097.2017 · Cited by 17
(2005) · Humana Press eBooks · doi:10.1385/1592599400 · Cited by 17
Microbiota and Alcoholic Liver Disease
Chen, P., Miyamoto, Y., Mazagova, M., Lee, K., Eckmann, L., & Schnabl, B. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13129 · Cited by 8
Belluomini, M., & Tagusagawa, H. K. (1984) · Revista de Saúde Pública · doi:10.1590/s0034-89101984000600005 · Cited by 4
Iredale, J. P., & Pellicoro, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.025 · Cited by 2
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Hepatic inflammatory responses in liver fibrosis
Hammerich, L., & Tacke, F. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00807-x · Cited by 803
“In general, evidence from preclinical studies, clinical trials and clinical observations suggests that fibrosis is reversible 9 .”
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
“The HSCs-secreted ECM promotes transformation from fibroblasts to myofibroblasts.(115,116) As a result, the normal liver tissues were replaced by the cross-linked type I and type III collagen fibers.”
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
Metadata
- Authors
- Kisseleva, T., & Brenner, D.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Kisseleva, Tatiana
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2020-10-30
- Volume
- 18
- Issue
- 3
- Pages
- 151-166
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3095484986
- Cited by
- 2,024
- References
- 299
- Citations by year
- 2026: 384 · 2025: 495 · 2024: 439 · 2023: 359 · 2022: 256 · 2021: 87 · 2020: 3
- FWCI
- 23.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver fibrosis, fibrosis regression, hepatic stellate cells, myofibroblasts, apoptosis, bone marrow-derived macrophages, myeloid cells, extracellular matrix, liver regeneration, chronic liver injury, fibrosis resolution
- MeSH terms
- Humans, Liver Cirrhosis, Hepatocytes, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.